Leukemia Clinical Trials in Cleveland

Showing 1201-1220 of 1,477 trials

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

NCT02276560

The purpose of this research study is to determine whether giving cisplatin and nab-paclitaxel before surgery will reduce the presence of disease in certain areas of the lung at the time of surgery.

Stage IIIA Non-Small Cell Lung Cancer

UNC Lineberger Comprehensive Cancer Center1 participantsStarted Jan 2015

Tampa, Florida, United States • Atlanta, Georgia, United States • Kansas City, Kansas, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects

NCT00652028

The objective of this study is to characterize the pharmacokinetic and pharmacodynamic profile of dexmedetomidine administered as an intravenous loading dose followed by a continuous intravenous infusion in pediatric subjects ages ≥2 through \<17 years old.

Intubated and Mechanically Ventilated Pediatric Subjects

Hospira, now a wholly owned subsidiary of Pfizer69 participantsStarted Nov 2008

Miami, Florida, United States • Louisville, Kentucky, United States • Buffalo, New York, United States +6 more locations

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects

Leukemia Trials in Other Cities

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

Study of the Glutaminase Inhibitor CB-839 in Leukemia

Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Other Conditions in Cleveland